405 related articles for article (PubMed ID: 19906951)
1. Histone deacetylase modulates the proinflammatory and -fibrotic changes in tubulointerstitial injury.
Marumo T; Hishikawa K; Yoshikawa M; Hirahashi J; Kawachi S; Fujita T
Am J Physiol Renal Physiol; 2010 Jan; 298(1):F133-41. PubMed ID: 19906951
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury.
Noh H; Oh EY; Seo JY; Yu MR; Kim YO; Ha H; Lee HB
Am J Physiol Renal Physiol; 2009 Sep; 297(3):F729-39. PubMed ID: 19553350
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of histone deacetylase activates side population cells in kidney and partially reverses chronic renal injury.
Imai N; Hishikawa K; Marumo T; Hirahashi J; Inowa T; Matsuzaki Y; Okano H; Kitamura T; Salant D; Fujita T
Stem Cells; 2007 Oct; 25(10):2469-75. PubMed ID: 17641247
[TBL] [Abstract][Full Text] [Related]
4. Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate.
Sekhavat A; Sun JM; Davie JR
Biochem Cell Biol; 2007 Dec; 85(6):751-8. PubMed ID: 18059533
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of histone deacetylases protects septic mice from lung and splenic apoptosis.
Takebe M; Oishi H; Taguchi K; Aoki Y; Takashina M; Tomita K; Yokoo H; Takano Y; Yamazaki M; Hattori Y
J Surg Res; 2014 Apr; 187(2):559-70. PubMed ID: 24290430
[TBL] [Abstract][Full Text] [Related]
6. Prevention of renal interstitial fibrosis via histone deacetylase inhibition in rats with unilateral ureteral obstruction.
Kinugasa F; Noto T; Matsuoka H; Urano Y; Sudo Y; Takakura S; Mutoh S
Transpl Immunol; 2010 May; 23(1-2):18-23. PubMed ID: 20206695
[TBL] [Abstract][Full Text] [Related]
7. Modulation of immunoglobulin gene conversion frequency and distribution by the histone deacetylase HDAC2 in chicken DT40.
Lin W; Hashimoto S; Seo H; Shibata T; Ohta K
Genes Cells; 2008 Mar; 13(3):255-68. PubMed ID: 18298800
[TBL] [Abstract][Full Text] [Related]
8. α2-Adrenoceptor agonist dexmedetomidine protects septic acute kidney injury through increasing BMP-7 and inhibiting HDAC2 and HDAC5.
Hsing CH; Lin CF; So E; Sun DP; Chen TC; Li CF; Yeh CH
Am J Physiol Renal Physiol; 2012 Nov; 303(10):F1443-53. PubMed ID: 22933299
[TBL] [Abstract][Full Text] [Related]
9. Statins increase p21 through inhibition of histone deacetylase activity and release of promoter-associated HDAC1/2.
Lin YC; Lin JH; Chou CW; Chang YF; Yeh SH; Chen CC
Cancer Res; 2008 Apr; 68(7):2375-83. PubMed ID: 18381445
[TBL] [Abstract][Full Text] [Related]
10. TGFbeta mediated transition of corneal fibroblasts from a proinflammatory state to a profibrotic state through modulation of histone acetylation.
Zhou Q; Yang L; Wang Y; Qu M; Chen P; Wang Y; Xie L; Zhao J; Wang Y
J Cell Physiol; 2010 Jul; 224(1):135-43. PubMed ID: 20232294
[TBL] [Abstract][Full Text] [Related]
11. Simvastatin attenuates renal inflammation, tubular transdifferentiation and interstitial fibrosis in rats with unilateral ureteral obstruction.
Vieira JM; Mantovani E; Rodrigues LT; Dellê H; Noronha IL; Fujihara CK; Zatz R
Nephrol Dial Transplant; 2005 Aug; 20(8):1582-91. PubMed ID: 15855201
[TBL] [Abstract][Full Text] [Related]
12. Trichostatin A induces 5-lipoxygenase promoter activity and mRNA expression via inhibition of histone deacetylase 2 and 3.
Pufahl L; Katryniok C; Schnur N; Sorg BL; Metzner J; Grez M; Steinhilber D
J Cell Mol Med; 2012 Jul; 16(7):1461-73. PubMed ID: 21883892
[TBL] [Abstract][Full Text] [Related]
13. Hyperoxia arrests alveolar development through suppression of histone deacetylases in neonatal rats.
Zhu L; Li H; Tang J; Zhu J; Zhang Y
Pediatr Pulmonol; 2012 Mar; 47(3):264-74. PubMed ID: 21905265
[TBL] [Abstract][Full Text] [Related]
14. Troglitazone inhibits histone deacetylase activity in breast cancer cells.
Davies GF; Ross AR; Arnason TG; Juurlink BH; Harkness TA
Cancer Lett; 2010 Feb; 288(2):236-50. PubMed ID: 19699029
[TBL] [Abstract][Full Text] [Related]
15. Opposed regulation of type I IFN-induced STAT3 and ISGF3 transcriptional activities by histone deacetylases (HDACS) 1 and 2.
Icardi L; Lievens S; Mori R; Piessevaux J; De Cauwer L; De Bosscher K; Tavernier J
FASEB J; 2012 Jan; 26(1):240-9. PubMed ID: 21957129
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase (HDAC) 1 and 2 expression and chemotherapy in gastric cancer.
Mutze K; Langer R; Becker K; Ott K; Novotny A; Luber B; Hapfelmeier A; Göttlicher M; Höfler H; Keller G
Ann Surg Oncol; 2010 Dec; 17(12):3336-43. PubMed ID: 20585871
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of MMTV transcription by HDAC inhibitors occurs independent of changes in chromatin remodeling and increased histone acetylation.
Mulholland NM; Soeth E; Smith CL
Oncogene; 2003 Jul; 22(31):4807-18. PubMed ID: 12894222
[TBL] [Abstract][Full Text] [Related]
18. [The effects of a histone deacetylase (HDAC) inhibitor on endotoxin-induced endothelial cell injury].
He HM; Li A; Zhang SW; Duan ML
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 Oct; 23(10):602-4. PubMed ID: 22005560
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase 1/2 mediates proliferation of renal interstitial fibroblasts and expression of cell cycle proteins.
Pang M; Ma L; Liu N; Ponnusamy M; Zhao TC; Yan H; Zhuang S
J Cell Biochem; 2011 Aug; 112(8):2138-48. PubMed ID: 21465537
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of histone deacetylase activity suppresses epithelial-to-mesenchymal transition induced by TGF-beta1 in human renal epithelial cells.
Yoshikawa M; Hishikawa K; Marumo T; Fujita T
J Am Soc Nephrol; 2007 Jan; 18(1):58-65. PubMed ID: 17135397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
